Dow Up 1.63% Nasdaq Up 0.97%

RedHill Biopharma Ltd. (RDHL)

-NasdaqCM
10.25 0.44(4.49%) Oct 17, 3:59PM EDT
Prev Close:9.81
Open:10.25
Bid:9.06 x 1000
Ask:10.46 x 500
1y Target Est:26.00
Beta:0.071
Next Earnings Date:N/A
Day's Range:10.25 - 10.25
52wk Range:8.50 - 21.00
Volume:1,250
Avg Vol (3m):6,054
Market Cap:89.74M
P/E (ttm):N/A
EPS (ttm):-0.98
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for RDHL

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):12.25
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.16
Quarterly EPS Est (Sep-14) :-0.50
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

RedHill Biopharma Ltd. is an Israeli biopharmaceutical company focused primarily on the development and acquisition of late clinical-stage, proprietary drugs for the treatment of inflammatory and gastrointestinal diseases, including gastrointestin... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback